What is HeartLab?
Headquartered in Auckland, New Zealand, HeartLab provides an end-to-end software solution designed to optimize the analysis and management of echocardiograms. The platform serves as a comprehensive tool for clinicians, facilitating the sorting and interpretation of complex ultrasound imagery while automating the generation of patient reports. By integrating directly into existing health records, HeartLab effectively removes administrative bottlenecks, allowing medical professionals to focus on patient outcomes rather than manual data entry. The company occupies a strategic niche at the intersection of deep tech and clinical cardiology, addressing the growing demand for automated, high-fidelity diagnostic tools in modern healthcare environments.
How much funding has HeartLab raised?
HeartLab has raised a total of $3.3M across 2 funding rounds:
Angel/Seed
$800K
Angel/Seed
$2.5M
Angel/Seed (2020): $800K with participation from Founders Fund and Icehouse Ventures
Angel/Seed (2021): $2.5M led by Outset Ventures, Icehouse Ventures, and Founders Fund
Key Investors in HeartLab
Outset Ventures
A New Zealand-based deep tech venture fund that provides specialized laboratory space and strategic support to help founders transform ambitious concepts into global enterprises.
Icehouse Ventures
One of New Zealand's most active early-stage venture firms, managing a diverse portfolio and a vast network of co-investors dedicated to backing brave founders.
Founders Fund
A prominent venture capital firm known for its founder-friendly investment strategy and a history of backing transformative companies across various global sectors.
What's next for HeartLab?
With the recent influx of capital, HeartLab is poised to transition into a phase of rapid enterprise-level scaling. The strategic roadmap likely involves enhancing its proprietary image analysis algorithms and expanding its market reach beyond its domestic base. As the company continues to refine its software, the focus will remain on deepening its integration capabilities within hospital information systems, thereby solidifying its role as an essential component of the modern cardiology department. The ongoing support from its investor base suggests a long-term commitment to establishing HeartLab as a global standard for cardiovascular diagnostic workflows.
See full HeartLab company page
